Parker Brogdon

Recent Posts

Pfizer and Mylan, the maker of EpiPens, are merging. Pfizer will offload Upjohn, its portfolio of drugs that are no longer protected by patents, including Viagra, Lipitor and Celebrex, combining with rival Mylan to create a new company that will have a new, yet-to-be-announced name.
United Technologies, an American multinational conglomerate, recently agreed to combine its aerospace business with military contractor Raytheon, creating a new manufacturing giant in the aerospace and defense sectors. Under the new name of Raytheon Technologies, the merged company would have about $74 billion in expected sales for 2019. 
When looking for outside counsel, companies are likely hearing similar pitches from all law firms. Business intelligence can be a powerful differentiator, a tool that helps law firms identify areas of strength and discover new pathways to success. It can lead to more focused marketing efforts and a general uptick in client buy-in.
In 2013, the USPTO enacted the After Final Consideration Pilot (AFCP) 2.0 program as an alternative response to a final rejection. The goal of the program was to increase communication between examiners and applicants and take those applications that are close to allowance across the finish line, without requiring the time and cost inevitably associated with an RCE.
Thanks to Juristat examiner analytics, patent practitioners can now leverage data to shape prosecution strategy based on the decision history of an assigned examiner. Here are  three essential (and often overlooked) examiner analytics that can lead to a more strategic prosecution.
Sprint and T-Mobile recently announced that they had reached a deal to merge, promising to “be a force for positive change in the U.S. wireless, video, and broadband industries.” Combining the country’s third and fourth largest mobile service providers would be one of the most significant consolidations in the American wireless market in years.
Thanks to Juristat patent analytics, practitioners can now leverage data to make strategic decisions throughout the patent prosecution process. Watch our latest video to learn how firms and in-house teams can shape strategy with big data during all parts of the prosecution process.
Due to inconsistent interpretation, preparing for and responding to Alice rejections has become one of the most stressful aspects of patent prosecution. Rejections citing Alice have multiplied exponentially since the initial decision on June 19, 2014, and they now account for more than 60% of §101 rejections and more than 8% of all rejections, as of our latest analysis.
Two of the biggest pharmaceutical companies are joining forces in a blockbuster merger. Bristol-Myers Squibb is buying Celgene in a cash and stock deal valued at about $74 billion.
On Sunday, February 24, film fans, pop culture fanatics, and all of Hollywood’s brightest stars will tune in to the live broadcast of the 91st Oscars ceremony. With eight movies nominated for best picture, from the bombastic Queen biopic Bohemian Rhapsody to the devastatingly poetic Roma, the ceremony is guaranteed to be star-studded, ornate, and maybe even a little unpredictable.

What's Next: CES 2019

January 24, 2019
As more and more of our daily life becomes automated, analyzed, and interconnected, people look forward to the Consumer Electronics Show (CES) every year to learn about emerging tech and its potential application to everyday life.
If you were following patent and innovation news in 2018, it was hard to avoid mentions of 3D printing.
Data-driven decisions can help shape a more successful patent prosecution and business development strategy, but navigating the complex data isn’t always an easy task. With the "Table View" in Juristat Platform, you can organize application reports by selecting from more than 125 different data points. Watch our latest video to learn how to extract informative data sets to improve your patent...
IBM recently took a giant step forward to position itself as a leader in the new frontier of cloud computing.
As patent lawyers working with creators and innovators, you rely on complex data and historical trends to make informed decisions in your patent prosecutions. Juristat organizes and visualizes big data to help patent prosecutors identify the most advantageous responses to office actions while providing clients with unparalleled transparency into the decision-making process. Watch our latest...
All companies applying for patents need to stay up to date on competitor activity that may threaten the viability of their patent applications. Juristat Platform consolidates Public PAIR information to help companies identify and monitor pending competitor applications for new developments. Learn how to narrow your search to competitor applications in relevant tech areas and create a saved...
With 15 consecutive years on the Fortune 500 list, Monsanto has had a huge impact on innovation in modern farming and biotech. As a patent analytics company, we were curious to see how Bayer's recent acquisition of Monsanto impacts their IP portfolio.
Last week, we identified the ten Most Difficult Examiners currently reviewing applications at the USPTO. By understanding how an examiner has performed in the past, patent professionals can manage client expectations and structure a prosecution strategy that maximizes an application’s likelihood of allowance. Through Juristat’s Examiner Reports, you can dive deeper into the decision-making...
Knowing an examiner’s allowance rate is one of the best indicators of how difficult a patent prosecution will be. Understanding how an examiner has performed in the past allows patent professionals to manage client expectations and structure a prosecution strategy that maximizes an application’s likelihood of allowance.